Profile data is unavailable for this security.
About the company
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
- Revenue in USD (TTM)1.07m
- Net income in USD-14.25m
- Incorporated2004
- Employees32.00
- LocationFemasys Inc3950 JOHNS CREEK COURT, SUITE 100SUWANEE 30024United StatesUSA
- Phone+1 (770) 500-3910
- Websitehttp://www.femasys.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ekso Bionics Holdings Inc | 17.91m | -14.24m | 25.08m | 70.00 | -- | 1.78 | -- | 1.40 | -0.9685 | -0.9685 | 1.20 | 0.7765 | 0.5423 | 1.65 | 3.38 | 255,900.00 | -43.11 | -43.63 | -57.86 | -57.67 | 50.41 | 51.93 | -79.48 | -104.24 | 2.11 | -34.63 | 0.2937 | -- | 41.57 | 10.03 | -0.7825 | -- | 3.69 | -- |
| SANUWAVE Health Inc | 20.40m | -25.81m | 25.09m | 31.00 | -- | -- | -- | 1.23 | -0.0455 | -0.0455 | 0.0257 | -0.0379 | 0.9647 | 3.16 | 5.56 | 657,967.80 | -122.05 | -136.54 | -- | -- | 70.41 | 69.13 | -126.52 | -189.60 | 0.1055 | -0.0214 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| Positron Corp | 1.24m | -1.27m | 28.67m | 22.00 | -- | -- | -- | 23.18 | -0.0897 | -0.0897 | 0.0876 | -0.1109 | 0.5976 | 2.29 | 6.56 | -- | -61.35 | -224.13 | -- | -- | 32.98 | 9.85 | -102.67 | -201.87 | 0.0638 | -- | -- | -- | -10.06 | 0.2751 | 63.63 | -- | 4.36 | -- |
| Neuroone Medical Technologies Corp | 2.86m | -13.47m | 29.04m | 16.00 | -- | 6.29 | -- | 10.17 | -0.6922 | -0.6922 | 0.1424 | 0.1779 | 0.369 | 1.66 | 8.94 | 178,516.30 | -174.02 | -172.88 | -211.08 | -274.74 | 27.16 | -- | -471.65 | -674.97 | 2.52 | -- | 0.00 | -- | 62.66 | -- | -18.60 | -- | -- | -- |
| BioRegenx Inc | 22.24k | -571.17k | 29.66m | 10.00 | -- | -- | -- | 1,333.43 | -0.0021 | -0.0021 | 0.00008 | -0.0008 | 0.4899 | -- | -- | 2,224.00 | -1,258.22 | -- | -- | -- | 96.85 | -- | -2,568.21 | -- | -- | -13.23 | 66.29 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| Femasys Inc | 1.07m | -14.25m | 30.89m | 32.00 | -- | 1.64 | -- | 28.81 | -0.9396 | -0.9396 | 0.0697 | 0.8474 | 0.048 | 0.6886 | 12.16 | 33,498.75 | -63.81 | -- | -71.11 | -- | 64.54 | -- | -1,329.07 | -- | 7.37 | -- | 0.2675 | -- | -11.13 | -- | -25.04 | -- | -- | -- |
| Akili Inc | 1.68m | -59.49m | 31.91m | 68.00 | -- | 0.5435 | -- | 19.02 | -0.761 | -0.761 | 0.0215 | 0.747 | 0.0149 | -- | 9.84 | 24,676.47 | -52.90 | -- | -59.98 | -- | 51.19 | -- | -3,545.47 | -- | -- | -27.18 | 0.1817 | -- | 419.50 | -- | -212.48 | -- | -- | -- |
| Harvard Apparatus Regenertv Tchnlgy Inc | 103.00k | -9.02m | 32.21m | 10.00 | -- | 19.07 | -- | 312.71 | -0.6801 | -0.6801 | 0.0077 | 0.118 | 0.0411 | -- | -- | 10,300.00 | -356.80 | -330.30 | -666.79 | -1,524.88 | 76.70 | -- | -8,684.47 | -35,138.84 | 0.7572 | -- | 0.00 | -- | -- | -- | -44.28 | -- | -39.07 | -- |
| Retractable Technologies Inc | 43.60m | -7.24m | 32.48m | 148.00 | -- | 0.3279 | 114.28 | 0.745 | -0.242 | -0.242 | 1.46 | 3.32 | 0.2323 | 1.80 | 5.62 | 294,573.80 | -3.74 | 12.45 | -3.96 | 14.51 | 20.89 | 40.82 | -16.08 | 18.09 | 6.41 | -3.15 | 0.0153 | -- | -54.02 | 5.55 | -249.46 | -- | 17.42 | -- |
| SeaStar Medical Holding Corp | 0.00 | -26.23m | 32.70m | 12.00 | -- | -- | -- | -- | -1.28 | -1.28 | 0.00 | -0.2913 | 0.00 | -- | -- | 0.00 | -800.85 | -- | -- | -- | -- | -- | -- | -- | -- | -26.51 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| Precision Optics Corporation Inc | 19.22m | -1.72m | 34.69m | 84.00 | -- | 3.06 | -- | 1.80 | -0.289 | -0.289 | 3.27 | 1.87 | 1.09 | 4.31 | 5.09 | 228,782.90 | -9.77 | -6.71 | -13.54 | -10.55 | 33.35 | 33.65 | -8.94 | -5.02 | 1.10 | -10.39 | 0.1823 | -- | 34.23 | 39.12 | 84.42 | -- | 19.39 | -- |
| Inspira Technologies Oxy BHN Ltd | 0.00 | -11.29m | 36.14m | 37.00 | -- | 5.70 | -- | -- | -0.9549 | -0.9549 | 0.00 | 0.3666 | 0.00 | -- | -- | 0.00 | -88.60 | -114.98 | -108.36 | -159.56 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.64 | -- | -- | -- |
| Nutriband Inc | 2.09m | -5.49m | 36.97m | 13.00 | -- | 4.64 | -- | 17.73 | -0.6863 | -0.6863 | 0.2622 | 0.7267 | 0.2457 | 6.15 | 15.94 | -- | -64.63 | -55.21 | -72.05 | -66.74 | 41.34 | 33.32 | -263.05 | -315.87 | 0.854 | -82.63 | 0.0312 | -- | 0.2741 | 53.43 | -22.35 | -- | 65.57 | -- |
| iCAD Inc | 17.32m | -7.01m | 37.97m | 67.00 | -- | 1.14 | -- | 2.19 | -0.2742 | -0.1925 | 0.6747 | 1.27 | 0.3719 | 0.8034 | 2.16 | 258,477.60 | -15.06 | -23.94 | -19.23 | -34.14 | 85.37 | 76.96 | -40.48 | -45.02 | 4.26 | -- | 0.00 | -- | -12.54 | -7.53 | 29.32 | -- | 23.88 | -- |
Data as of May 09 2024. Currency figures normalised to Femasys Inc's reporting currency: US Dollar USD
6.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| CM Management LLCas of 31 Dec 2023 | 450.00k | 2.08% |
| Clear Creek Financial Management LLCas of 31 Mar 2024 | 309.27k | 1.43% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 155.26k | 0.72% |
| Geode Capital Management LLCas of 31 Dec 2023 | 138.22k | 0.64% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 69.23k | 0.32% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 57.59k | 0.27% |
| City National Rochdale LLCas of 31 Dec 2023 | 52.94k | 0.25% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 39.67k | 0.18% |
| Tri Locum Partners LPas of 31 Dec 2023 | 36.15k | 0.17% |
| HB Wealth Management LLC (GA)as of 31 Mar 2024 | 35.47k | 0.16% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
